Treatment of serpiginous choroiditis with intravitreous fluocinolone acetonide implant

Rajeev K. Seth, Paul A. Gaudio

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Purpose: To describe a case in which a fluocinolone acetonide implant was used in a patient with serpiginous choroiditis. Design: Case report. Results: A 57-year-old woman with active serpiginous choroiditis threatening the fovea of her right eye received one intravitreous triamcinolone acetonide injection, leading to immediate disease control. An intravitreous fluocinolone acetonide implant was placed, and resulted in ongoing control of the disease as of her 14 months postoperative follow-up. Conclusions: Intravitreous fluocinolone acetonide implant should be recognized as a potential treatment option for serpiginous choroiditis.

Original languageEnglish (US)
Pages (from-to)103-105
Number of pages3
JournalOcular Immunology and Inflammation
Issue number3
StatePublished - May 2008
Externally publishedYes


  • Fluocinolone acetonide
  • Intravitreous implant
  • Retisert
  • Serpiginous choroiditis
  • Triamcinolone acetonide

ASJC Scopus subject areas

  • Immunology and Allergy
  • Ophthalmology


Dive into the research topics of 'Treatment of serpiginous choroiditis with intravitreous fluocinolone acetonide implant'. Together they form a unique fingerprint.

Cite this